Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity (Q29365197)

2

0 references

Tianli Xia

3

0 references

Jeonghyun Ahn

4

0 references

Glen N. Barber

5

0 references

language of work or name

English

0 references

publication date

13 March 2017

0 references

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Journal of Immunology

1 reference

on focus list of Wikimedia project

PubMed

volume

198

0 references

issue

8

0 references

page(s)

3023-3028

0 references

WikiProject Zika Corpus

0 references

cites work

Zika virus: History, emergence, biology, and prospects for control

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Zika Virus: Implications for Public Health

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Zika Virus and Birth Defects — Reviewing the Evidence for Causality

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Potential sexual transmission of Zika virus

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Zika Virus: Immunity and Vaccine Development

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Scoping Review of the Zika Virus Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Vesicular stomatitis virus (VSV) therapy of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1602180